Feasibility and long-term results of focused radioguided parathyroidectomy using a "low" 37 MBq (1 mCi) 99mTc-sestamibi protocol
Tóm tắt
Aim of the present study was to investigate the feasibility and long-term results of focused radioguided parathyroidectomy using a "low" 37 MBq (1 mCi) 99mTc-sestamibi dose protocol compared to conventional "high 740 MBq (20 mCi) 99mTc-sestamibi dose protocol" in patients with primary hyperparathyroidism (PHPT). The data of focused radioguided surgery obtained in a group of 320 consecutive PHPT patients with high probability of the presence of a solitary parathyroid adenoma (PA) were studied. All patients underwent preoperative imaging work-up of double-tracer 99mTc-pertechnetate/99mTc-sestamibi subtraction parathyroid scintigraphy (Sestamibi scintigraphy) and high resolution neck ultrasound (US). In 301/320 patients (96.6%) focused minimally invasive radioguided surgery was successfully performed by administering a "low" 37 MBq (1 mCi) 99mTc-sestamibi dose in the operating room 10 minutes before operation. No major intraoperative complications were recorded. Focused radioguided surgery required a mean time of 32 min and a mean hospital stay of 1.2 days. Local anesthesia was applied in 75 patients, 66 of whom (88%) were patients older than 65 years with comorbidities contraindicating general anesthesia. No case of persistent or recurrent PHPT was observed during post-surgical follow-up (range = 18–70 months; mean +/- SD = 15.3 +/- 9.1 months). Radiation exposure dose to the operating surgeon was 1.2 μSi/hour with the "low 37 MBq (1 mCi) 99mTc-sestamibi dose", and less than 1.0 μSi/hour for the other operating-room personnel. Focused low dose radioguided parathyroidectomy is a safe and effective means to localize parathyroid adenomas in patients affected by solitary PA thus reducing by 20 fold the radiation exposure dose to the patients and operating room personnel.
Tài liệu tham khảo
Sackett WR, Barraclough B, Reeve TS, Delbridge LW: Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg. 2002, 137: 1055-1059. 10.1001/archsurg.137.9.1055.
Rubello D, Pelizzo MR, Casara D: Nuclear medicine and minimally invasive surgery of parathyroid adenomas: a fair marriage (editorial). Eur J Nucl Med. 2002, 30: 189-192.
Rubello D, Fig LM, Casara D, Piotto A, Boni G, Pelizzo MR, Mariani G: Radioguided surgery of parathyroid adenomas and recurrent thyroid cancer using the "low sestamibi dose"protocol. Cancer Biother Radiopharm. 2006, 21: 194-205. 10.1089/cbr.2006.21.194.
Rubello D, Casara D, Pelizzo MR: Symposium on parathyroid localising imaging. Optimization of peroperative procedures. Nucl Med Commun. 2003, 24: 133-140. 10.1097/00006231-200302000-00005.
Casara D, Rubello D, Piotto A, Pelizzo MR: 99mTc-MIBI radio-guided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MIBI and ultrasound imaging protocol. Eur J Nucl Med. 2000, 27: 1300-1304. 10.1007/s002590000297.
Casara D, Rubello D, Pelizzo MR, Shapiro B: Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med. 2001, 28: 1351-1359. 10.1007/s002590100564.
Rubello D, Casara D, Giannini S, Piotto A, De Carlo E, Muzzio PC, Pelizzo MR: Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low 99mTc-MIBI dose: technical considerations and long-term clinical results. Q J Nucl Med. 2003, 47: 129-138.
Rubello D, Piotto A, Casara D, Muzzio PC, Shapiro B, Pelizzo MR: Role of gamma probes in performing minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: optimization of preoperative and intraoperative procedures. Eur J Endocrinol. 2003, 149: 7-15. 10.1530/eje.0.1490007.
Tibblin S, Bondeson AG, Ljubgberg O: Unilateral parathyroidectomy in hyperparathyroidism due to a single adenoma. Ann Surg. 1982, 195: 245-252.
Gagner M: Endoscopic parathyroidectomy (letter). Br J Surg. 1996, 83: 875-
Henry JF, Iacobone M, Mirallie E, Deveze A, Pili S: Indications and results of video-assisted parathyroidectomy by a lateral approach in patients with primary hyperparathyroidism. Surgery. 2001, 130: 999-1004. 10.1067/msy.2001.119112.
Norman J, Chheda H: Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery. 1997, 122: 998-1004. 10.1016/S0039-6060(97)90201-4.
Costello D, Norman J: Minimally invasive radioguided parathyroidectomy. Surg Oncol Clin N Am. 1999, 8: 555-564.
Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR: Preoperative localization and radioguided parathyroid surgery. J Nucl Med. 2003, 44: 1443-1458.
Coakley AJ, Kettle AG, Wells CP, O'Doherty MJ, Collings REC: 99mTc-sestamibi – a new agent for parathyroid imaging. Nucl Med Commun. 1989, 10: 791-794.
Taillefer R, Boucher Y, Potvin C, Lambert R: Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-Sestamibi (double-phase study). J Nucl Med. 1992, 33: 1801-1807.
O'Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ: Parathyroid imaging with technetium-99m-Sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992, 33: 313-318.
Hindié E, Melliere D, Jeanguillaume C, Perlemuter L, Chehade F, Galle P: Parathyroid imaging using simultaneous double-window recording of Technetium-99m-sestamibi and iodine-123. J Nucl Med. 1998, 39: 1100-1105.
Coakley AJ: Symposium on parathyroid localization (editorial). Nucl Med Commun. 2003, 24: 111-113. 10.1097/00006231-200302000-00001.
Rubello D, Saladini G, Casara D, Borsato N, Toniato A, Piotto A, Pelizzo MR: Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy. A fast and effective technique. Clin Nucl Med. 2000, 25: 527-531. 10.1097/00003072-200007000-00007.
Irvin GL, Dembrow VD, Prudhomme DL: Clinical usefulness of an intraoperative "quick PTH" assay. Surgery. 1993, 114: 1019-1023.
Sfakianakis GN, Irvin GL, Foss J: Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med. 1996, 37: 798-804.
Moka D, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H: Technetium 99m-MIBI-SPECT: a high sensitive diagnostic tool for localization of parathyroid adenomas. Surgery. 2000, 128: 29-35. 10.1067/msy.2000.107066.
Norman J, Rubello D, Giuliano AE, Mariani G: Minimally invasive radioguided parathyroidectomy in primary hyperparathyroidism. Radioguided Surgery – A Comprehensive Team Approach Giuliano AE, Strauss HW. 2006, New York: Springer
Rubello D, Pelizzo MR, Boni G, Schiavo R, Vaggelli L, Villa G, Sandrucci S, Mariani G: Radioguided surgery of primary hyperparathyroidism using the low-dose 99mTc-sestamibi protocol: multi-institutional experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS). J Nucl Med. 2005, 46: 220-226.
Rubello D, Casara D, Giannini S, Piotto A, Dalle Carbonare L, Pagetta C, Pelizzo MR: Minimally invasive radioguided parathyroidectomy: an attractive therapeutic option for elderly patients with primary hyperparathyroidism. Nucl Med Commun. 2004, 25: 901-908. 10.1097/00006231-200409000-00007.